Rhelion Life Sciences Corp. (4YX0)
FSX
Real-time Data
06:00 AM
Day's Range
0.0020052 wk Range
0.00050Overview - 4YX0 - Rhelion Life Sciences Corp.
Key Statistics
Valuation
Enterprise Value
-1.23M
P/E (Trailing)
‪-0.60‬
Price / Sales (TTM)
‪1.42‬
Price / Book
‪0.46‬
EV / EBITDA
‪0.45‬
Profitability
Gross Margin
‪91.22%‬
Profit Margin
‪-181.28%‬
Operating Margin
‪-774.50%‬
Return on Assets
‪-13.71%‬
Return on Equity
‪-41.31%‬
Ownership
Shares Outstanding
614.12M
Float
575.17M
Held by Insiders
‪5.90%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪0.00787‬
200-Day Avg
‪0.0122‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 4YX0 - Rhelion Life Sciences Corp.
Peers - 4YX0 - Rhelion Life Sciences Corp.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 4YX0FSXRhelion Life Sciences Corp.5.46MMarket Cap-46.07%52-week change-0.61P/E (Trailing)‪-181.28%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - 4YX0 - Rhelion Life Sciences Corp.
About
Rhelion Life Sciences Corp. is a life sciences company focused on the research, development, and commercialization of natural psychedelic medicines and related products. The company operates a pharmaceutical development platform through its subsidiary Filament Health, where it advances naturally derived psilocybin…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
